A great deal of interest exists in the use of regulatory T cells for therapeutic purposes in autoimmune diseases such as rheumatoid arthritis. Two new studies highlight possible approaches to achieve this aim, but the jury is still out on whether these will become effective therapies.
- Richard O. Williams
- Wen-Yi Tseng
